Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.
---
Provenzano, George, Sandeep Duttagupta, Thomas McRae, et al. "Delays in Nursing Home Placement for Patients with Alzheimer s Disease Associated with Donepezil May Have Care Cost Savings Implications". Value in Health . Vol. 4, No. 2, pp. 158. [ Permalink ] |